SCHEMBL1614734

SCHEMBL1614734

Cc1nn2c(=O)cc(-c3ccc(Cl)cc3)[nH]c2c1-c1cccs1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.40
ALDH1A1 P00352 4/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
LMNA P02545 1/20 0.39
ADORA3 P0DMS8 2/20 0.39
ADORA2A P29274 1/20 0.39
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
PDE2A O00408 1/20 0.36
TYMP P19971 1/20 0.36
MAPT P10636 3/20 0.36
POLB P06746 3/20 0.36
CFTR P13569 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1613668 0.90 ADORA3 (0.39) MAPK14ALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL1614313 0.87 PIM1 (0.44) ALDH1A1MEN1KMT2AL3MBTL1LMNA
SCHEMBL13515966 0.85 MAPT (0.46) ALDH1A1MEN1KMT2AL3MBTL1LMNA
SCHEMBL1279377 0.84 ARF6 (0.46) MAPK14ALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL1613449 0.83 TP53 (0.48) MAPK14ALDH1A1MEN1KMT2ALMNA
SCHEMBL13516328 0.83 TP53 (0.48) MAPK14ALDH1A1MEN1KMT2ALMNA
SCHEMBL1613652 0.81 PARP1 (0.40) ALDH1A1LMNAADORA3TYMPMAPT
SCHEMBL1613743 0.81 SMN1; SMN2 (0.47) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL1613674 0.80 KCNQ3 (0.40) MAPK14ALDH1A1ADORA3ADORA2AGRIN2D
SCHEMBL1614330 0.80 KCNQ3 (0.47) ALDH1A1MEN1KMT2ALMNAADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof KCNJ2, KCNQ5, KCNJ11 MAPK14 2408/4885ALDH1A1 159/4885MEN1 1513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.